ATE307144T1 - Vip-verwandte peptide zur behandlung von sexuellen funktionsstörungen bei frauen - Google Patents
Vip-verwandte peptide zur behandlung von sexuellen funktionsstörungen bei frauenInfo
- Publication number
- ATE307144T1 ATE307144T1 AT01934287T AT01934287T ATE307144T1 AT E307144 T1 ATE307144 T1 AT E307144T1 AT 01934287 T AT01934287 T AT 01934287T AT 01934287 T AT01934287 T AT 01934287T AT E307144 T1 ATE307144 T1 AT E307144T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- vip
- conjugate
- women
- vaginal
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 230000001568 sexual effect Effects 0.000 title 1
- 206010057671 Female sexual dysfunction Diseases 0.000 abstract 3
- 206010051873 Vaginal relaxation Diseases 0.000 abstract 3
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 abstract 3
- 102000055135 Vasoactive Intestinal Peptide Human genes 0.000 abstract 2
- VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000019100 sperm motility Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13627400A IL136274A0 (en) | 2000-05-22 | 2000-05-22 | Pharmaceutical compositions comprising vip-related peptides |
| IL13897100A IL138971A0 (en) | 2000-10-12 | 2000-10-12 | Pharmaceutical compositions comprising vip-related peptides |
| PCT/IL2001/000460 WO2001090144A2 (en) | 2000-05-22 | 2001-05-22 | Vip-related peptides for the treatment of sexual disorders in women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE307144T1 true ATE307144T1 (de) | 2005-11-15 |
Family
ID=26323949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01934287T ATE307144T1 (de) | 2000-05-22 | 2001-05-22 | Vip-verwandte peptide zur behandlung von sexuellen funktionsstörungen bei frauen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050075284A1 (de) |
| EP (1) | EP1292618B1 (de) |
| JP (1) | JP2004517036A (de) |
| AT (1) | ATE307144T1 (de) |
| AU (1) | AU2001260580A1 (de) |
| CA (1) | CA2409592A1 (de) |
| DE (1) | DE60114194T2 (de) |
| WO (1) | WO2001090144A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020099003A1 (en) * | 1997-10-28 | 2002-07-25 | Wilson Leland F. | Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof |
| US7198834B2 (en) * | 2005-03-22 | 2007-04-03 | Hewlett-Packard Development Company, L.P. | Imaging media including interference layer for generating human-readable marking on optical media |
| US20090264363A1 (en) * | 2008-03-26 | 2009-10-22 | Ward Loren S | Leucine-Rich Peptide Compositions and Methods for Isolation |
| DK2533791T3 (en) * | 2009-12-21 | 2017-05-08 | Glanbia Nutritionals (Ireland) Ltd | LEUCIN-PEPTID COMPOSITION AND PROCEDURE FOR FORMULATION |
| ES2395801B1 (es) * | 2011-06-23 | 2014-06-06 | María Carmen PARDINA PALLEJÀ | "pentoxifilina por vía transvaginal para el tratamiento de la infertilidad" |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0463450T3 (da) * | 1990-06-26 | 1994-06-27 | Sanwa Kagaku Kenkyusho Co | Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf |
| US5998368A (en) * | 1991-10-31 | 1999-12-07 | Yeda Research And Development Co. Ltd. | Derivatives of structurally modified VIP and pharmaceutical compositions containing them |
| US5773457A (en) * | 1995-02-15 | 1998-06-30 | Cesar Roberto Dias Nahoum | Compositions |
| BR9203277A (pt) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao |
| IL118003A0 (en) * | 1996-04-23 | 1996-08-04 | Yeda Res & Dev | Novel vip fragments and pharmaceutical compositions comprising them |
| US6217886B1 (en) * | 1997-07-14 | 2001-04-17 | The Board Of Trustees Of The University Of Illinois | Materials and methods for making improved micelle compositions |
| US20020004529A1 (en) * | 1997-10-20 | 2002-01-10 | Gary W. Neal | Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| US6031002A (en) * | 1998-05-01 | 2000-02-29 | Michael Ebert | Method for enhancing female sexual response and a composition therefor |
| US6214849B1 (en) * | 1999-04-29 | 2001-04-10 | Lupin Laboratories Limited | Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans |
-
2001
- 2001-05-22 AT AT01934287T patent/ATE307144T1/de not_active IP Right Cessation
- 2001-05-22 EP EP01934287A patent/EP1292618B1/de not_active Expired - Lifetime
- 2001-05-22 JP JP2001586331A patent/JP2004517036A/ja active Pending
- 2001-05-22 DE DE60114194T patent/DE60114194T2/de not_active Expired - Fee Related
- 2001-05-22 AU AU2001260580A patent/AU2001260580A1/en not_active Abandoned
- 2001-05-22 US US10/240,392 patent/US20050075284A1/en not_active Abandoned
- 2001-05-22 CA CA002409592A patent/CA2409592A1/en not_active Abandoned
- 2001-05-22 WO PCT/IL2001/000460 patent/WO2001090144A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1292618A2 (de) | 2003-03-19 |
| AU2001260580A1 (en) | 2001-12-03 |
| DE60114194T2 (de) | 2006-07-13 |
| US20050075284A1 (en) | 2005-04-07 |
| JP2004517036A (ja) | 2004-06-10 |
| DE60114194D1 (de) | 2006-03-02 |
| WO2001090144A3 (en) | 2002-03-28 |
| WO2001090144A2 (en) | 2001-11-29 |
| CA2409592A1 (en) | 2001-11-29 |
| EP1292618B1 (de) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002041883A3 (en) | As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation | |
| EA200201000A1 (ru) | Гормон-заместительная терапия | |
| ATE265849T1 (de) | Zusammensetzungen und methoden zur verbesserung von sexuellen funktionsstörungen bei frauen | |
| ES2170050T3 (es) | Metodos y composiciones para inducir la ereccion. | |
| ATE365045T1 (de) | Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen,sowie damit verbundene zusammensetzungen und behandlungsformen | |
| ATE184794T1 (de) | Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz | |
| BR9702309A (pt) | Uso composição cosmética ou farmacêutica e processo de tratamento cosmético | |
| CR5959A (es) | Tratamiento para la disfuncion sexual femenina | |
| EA200301022A1 (ru) | Гормональная заместительная терапия | |
| NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
| EA200600029A1 (ru) | Фармацевтическая композиция для контрацепции и заместительной гормональной терапии | |
| UA90077C2 (uk) | Антидисритмічні агенти для лікування тазового болю, що призначаються вагінально | |
| CY1107478T1 (el) | Η χρηση της τραμαδολης για καθυστερηση της εκσπepματισης | |
| MXPA04005783A (es) | Formulacion farmaceutica que comprende ciclosporina y uso de la misma. | |
| DK1079803T3 (da) | Proteinholdige præparater | |
| DE60114194D1 (de) | Vip-verwandte peptide zur behandlung von sexuellen funktionsstörungen bei frauen | |
| PT1109814E (pt) | 5-heterociclil pirazol¬4,3-d|pirimidina-7-onas para o tratamento da disfuncao erectil masculina | |
| BR0111002A (pt) | Combinação de secretagogos do hormÈnio do crescimento e antidepressivos | |
| ES2134301T3 (es) | Composicion farmaceutica para la profilaxis y el tratamiento de la eyaculacion precoz. | |
| EA199700150A1 (ru) | КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC | |
| ATE307575T1 (de) | Zusammensetzung geeignet als nahrungsmittelzusatz und zur anwendung bei darmerkrankungen sowie bei veränderter darmflora | |
| WO2001019357A3 (de) | Kombinationspräparat zur behandlung von sexueller dysfunktion | |
| WO2003034998A3 (en) | Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis | |
| EP0971722B1 (de) | Aphrodisiakum zur anwendung an den geschlechtsorganen | |
| BRPI0416202A (pt) | formulações inibidoras de fosfodiesterase v |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |